Chunghwa Chemical Synthesis & Biotech Co., Ltd. — Investor Relations & Filings
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 112年第4季現金流量表 | 2024-03-28 | Chinese | |
| 112年第4季綜合損益表 | 2024-03-28 | Chinese | |
| 112年第4季資產負債表 | 2024-03-28 | Chinese | |
| 113年03月法人說明會簡報 — 176220240320E001.pdf | 2024-03-20 | Chinese | |
| 113年03月法人說明會簡報 — 176220240320M001.pdf | 2024-03-20 | Chinese | |
| 113年03月法人說明會簡報 | 2024-03-20 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 33466173 | 112年第4季現金流量表 | 2024-03-28 | Chinese | ||
| 33466163 | 112年第4季綜合損益表 | 2024-03-28 | Chinese | ||
| 33466155 | 112年第4季資產負債表 | 2024-03-28 | Chinese | ||
| 33466256 | 113年03月法人說明會簡報 — 176220240320E001.pdf | 2024-03-20 | Chinese | ||
| 33466233 | 113年03月法人說明會簡報 — 176220240320M001.pdf | 2024-03-20 | Chinese | ||
| 33466209 | 113年03月法人說明會簡報 | 2024-03-20 | Chinese | ||
| 33466262 | 本公司受邀參加富邦證券舉辦之法人說明會 | 2024-03-20 | Chinese | ||
| 33466267 | 本公司董事會決議辦理私募發行國內可轉換公司債（包括有擔保 或無擔保可轉換公司債） | 2024-03-11 | Chinese | ||
| 33466273 | 本公司董事會決議辦理私募發行普通股 | 2024-03-11 | Chinese | ||
| 33466279 | 公告本公司董事會決議不繼續辦理112年股東常會通過 之私募有價證券案 | 2024-03-11 | Chinese | ||
| 33466284 | 董事會決議股利分派 | 2024-03-11 | Chinese | ||
| 33466290 | 公告本公司董事會通過112年度合併財務報告 | 2024-03-11 | Chinese | ||
| 33466293 | 公告本公司董事會決議召開113年股東常會相關事宜 | 2024-03-11 | Chinese | ||
| 33466298 | 112年度股利金額(董事會決議) | 2024-03-11 | Chinese | ||
| 33466312 | 113年2月背書保證與資金貸與 | 2024-03-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51917/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51917 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51917 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51917 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51917}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (id: 51917)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.